Cargando…

Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years

We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otsuka, Yasuyuki, Nishikori, Momoko, Kitano, Toshiyuki, Oka, Tomomi, Ishikawa, Takayuki, Haga, Hironori, Takaori‐Kondo, Akifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378856/ https://www.ncbi.nlm.nih.gov/pubmed/28396772 http://dx.doi.org/10.1002/ccr3.872

Ejemplares similares

Relapse of follicular lymphoma arising from a non‐t(14;18) clone
por: Otsuka, Yasuyuki, et al.
Publicado: (2020)

Concurrent development of small lymphocytic lymphoma and lung cancer: A report of two cases and a review of the literature
por: Nakao, Kensuke, et al.
Publicado: (2023)

The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B‐cell lymphoma and enhances T‐cell recruitment
por: Yuan, Hepei, et al.
Publicado: (2021)

A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine
por: Umeda, Masayuki, et al.
Publicado: (2015)

A sporadic case of CTLA4 haploinsufficiency manifesting as Epstein–Barr virus-positive diffuse large B-cell lymphoma
por: Yuan, Hepei, et al.
Publicado: (2021)

SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma
por: Sugimoto, Akihiko, et al.
Publicado: (2020)

Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report
por: Nassereldine, Hasan, et al.
Publicado: (2022)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma
por: Dalland, Joanna C., et al.
Publicado: (2021)

Recurrent Epstein-Barr Virus-positive (EBV+) Primary Central Nervous System Lymphoma (PCNSL) in a Patient with Clinical Features of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)
por: Nagano, Masahiro, et al.
Publicado: (2019)

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2016)

Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy
por: Nakamura, Naokazu, et al.
Publicado: (2022)

Risk analysis of fluctuating hypercalcemia after leukapheresis in cellular therapy
por: Jo, Tomoyasu, et al.
Publicado: (2023)

Intravascular clusters of T cells following chimeric antigen receptor T cell therapy
por: Nakamura, Naokazu, et al.
Publicado: (2022)

EBV‐associated lymphoproliferative disorder in a patient with X‐linked severe combined immunodeficiency with multiple reversions of an IL2RG mutation in T cells
por: Wada, Fumiya, et al.
Publicado: (2020)

T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy
por: Wada, Fumiya, et al.
Publicado: (2022)

Venetoclax for the treatment of translocation (11;14) AL amyloidosis
por: Sidiqi, M. Hasib, et al.
Publicado: (2020)

A Rare Case of Adult Autoimmune Neutropenia Successfully Treated with Prednisolone
por: Fujita, Mari, et al.
Publicado: (2017)

IgE Plasma Cell Leukemia Harboring t(11;14) and 1q Amplification
por: Nakahara, Wataru, et al.
Publicado: (2023)

Granulocytic sarcoma of the pancreas on (18)F-FDG PET/CT: A case report
por: Ishii, Akira, et al.
Publicado: (2016)

Multiple myeloma with t(11;14): impact of novel agents on outcome
por: Puertas, Borja, et al.
Publicado: (2023)

Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants
por: Tajima, Tetsuya, et al.
Publicado: (2021)

Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2019)

Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study
por: Iwasaki, Makoto, et al.
Publicado: (2019)

Programmed cell death 1‐expressing CD56‐negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment
por: Ishiyama, Ken‐ichi, et al.
Publicado: (2020)

Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies
por: Morita-Fujita, Mari, et al.
Publicado: (2020)

Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?
por: Tajima, Tetsuya, et al.
Publicado: (2019)

Staphylococcus epidermidis meningitis in the absence of a neurosurgical device secondary to catheter-related bloodstream infection: a case report and review of the literature
por: Noguchi, Taro, et al.
Publicado: (2018)

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
por: Premkumar, Vikram J., et al.
Publicado: (2021)

Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma
por: Wang, Jinghua, et al.
Publicado: (2022)

Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation
por: Diamantidis, Michael D., et al.
Publicado: (2022)

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
por: Nguyen, Nina, et al.
Publicado: (2022)

Targeting BCL‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma
por: Kaufman, Jonathan L., et al.
Publicado: (2021)

T cell acute lymphoblastic leukemia with t(11;14)(p13;q11) and trisomy 8
por: Safavi, Moeinadin, et al.
Publicado: (2021)

Palbociclib regulates the expression of dihydrofolate reductase and the cell cycle to inhibit t (11;14) multiple myeloma
por: Wang, Yazhu, et al.
Publicado: (2022)

Is t(11;14)(q13;q32) good or bad for newly diagnosed multiple myeloma?
por: Liu, Yang, et al.
Publicado: (2023)

SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement
por: Szostakowska, Małgorzata, et al.
Publicado: (2018)

What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?
por: Gao, Wen, et al.
Publicado: (2020)

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
por: Jian, Yuan, et al.
Publicado: (2022)

Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis
por: Arai, Yasuyuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mqqfvki56svntgru9oegjdu5ql